Endiya Partners Blogs - Thought Leadership in Early-Stage Funding for SaaS, Healthcare, Fintech & Deeptech Startups

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

HealthCare

Dr. Ramesh Byrapaneni

March 4, 2021

Tele-ICU Opportunity: Myth or reality?

"At a macro level in Telehealth, it appears like there is a huge market opportunity because of the shortage of critical care doctors in many countries relative to their population. We must still consider that there are a lot of challenges that entrepreneurs have to overcome to build a large and viable business in the sector. Can these businesses be built like SaaS businesses?"

Intelligent Mobility

Abhishek Srivastava

September 9, 2020

Cell Propulsion - What made us cross the Chasm?

The 4th-largest automobile industry in the world needs a transformation - especially the commercial segment which comprises nearly 4% of the industry. Also, the world continues to grapple with climate change, as the stakes keep getting exponentially higher with each passing year. Cell Propulsion presents its solution as a model that is unique for multiple reasons, including but not limited to scalability, customization for the end customer, and a product that offers numerous avenues for diversification.

HealthCare

Dr. Ramesh Byrapaneni

June 15, 2020

Beyond Tertiary Hospitals and Home Health – The Missing Link

Indian Healthcare has evolved, the establishment of multi-speciality hospitals in tertiary and quaternary care to niche single speciality players, as well as a boom in home-health – the healthcare service offerings have been growing leaps and bounds. However, there are still some critical gaps in the industry and Transition or Long Term Care is one such area where we are yet to see a sophisticated solution reach nationwide presence, awareness and impact.

HealthCare

Dr. Ramesh Byrapaneni

June 4, 2020

COVID-19 drugs: Beyond the low hanging fruit

Given that the pandemic is likely to stay through 2021 and beyond and vaccine development is still at early stages, drugs have a critical role to play in the fight against the COVID-19 virus. Despite anecdotal evidence that some people benefit from drugs such as hydroxychloroquine and azithromycin, favipiravir and remdesivir, more data are needed to confirm their efficacy and safety.

No items found.

All Sectors

Sort By

Tele-ICU Opportunity: Myth or reality?

Cell Propulsion - What made us cross the Chasm?

Beyond Tertiary Hospitals and Home Health – The Missing Link

COVID-19 drugs: Beyond the low hanging fruit

Blogs

Filter Blogs

All Sectors

Sort By